Letters to the Editor

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden
Leiden University Medical Center, Leiden
Zentrales Knochenmarkspender-Register Deutschland, Ulm
Institute for Experimental Cellular Therapy, University Hospital Essen, Essen
Leiden University Medical Center, Leiden
Fred Hutchinson Cancer Research Center, Seattle
Hôpital St. Louis, Paris
Histocompatibility Laboratory, EFS Lyon
HUCH Comprehensive Cancer Center, Helsinki
Clinical Laboratory Services, Histocompatibility Testing, Finnish Red Cross Blood Service, Helsinki
CHU de Lille, Lille
Erasmus MC Cancer Institute, Rotterdam
Transplantation Immunology, Maastricht University Medical Center, Maastricht
Oslo University Hospital, Rikshospitalet, Oslo
CHU Bordeaux, Pessac
Addenbrookes Hospital, Cambridge
Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London,
Centre Hospitalier Universitaire de Rennes, Rennes
Manchester Royal Infirmary, Manchester
CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble
CHU - Institut Universitaire du Cancer Toulouse, Toulouse
University Medical Center Groningen (UMCG), Groningen
Hopital Jean Minjoz, Besancon
Turku University Hospital, Turku
Skanes University Hospital, Lund
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala
Sahlgrenska University Hospital, Goeteborg
University Hospital Maastricht, Maastricht
EBMT Leiden Study Unit, Leiden
San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden
Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31) of the Service of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, SP
San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden
Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille
Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen
Haematologica Early view May 12, 2022 https://doi.org/10.3324/haematol.2021.280055